Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients. (12th March 2020)
- Record Type:
- Journal Article
- Title:
- Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients. (12th March 2020)
- Main Title:
- Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients
- Authors:
- Kenter, Annegien T.
Rentmeester, Eveline
Riet, Job
Boers, Ruben
Boers, Joachim
Ghazvini, Mehrnaz
Xavier, Vanessa J.
Leenders, Geert J.L.H.
Verhagen, Paul C.M.S.
Til, Marjan E.
Eussen, Bert
Losekoot, Monique
Klein, Annelies
Peters, Dorien J.M.
IJcken, Wilfred F.J.
Werken, Harmen J.G.
Zietse, Robert
Hoorn, Ewout J.
Jansen, Gert
Gribnau, Joost H. - Abstract:
- Abstract: Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, leading to kidney failure in most patients. In approximately 85% of cases, the disease is caused by mutations in PKD1 . How dysregulation of PKD1 leads to cyst formation on a molecular level is unknown. Induced pluripotent stem cells (iPSCs) are a powerful tool for in vitro modeling of genetic disorders. Here, we established ADPKD patient-specific iPSCs to study the function of PKD1 in kidney development and cyst formation in vitro. Somatic mutations are proposed to be the initiating event of cyst formation, and therefore, iPSCs were derived from cystic renal epithelial cells rather than fibroblasts. Mutation analysis of the ADPKD iPSCs revealed germline mutations in PKD1 but no additional somatic mutations in PKD1/PKD2 . Although several somatic mutations in other genes implicated in ADPKD were identified in cystic renal epithelial cells, only few of these mutations were present in iPSCs, indicating a heterogeneous mutational landscape, and possibly in vitro cell selection before and during the reprogramming process. Whole-genome DNA methylation analysis indicated that iPSCs derived from renal epithelial cells maintain a kidney-specific DNA methylation memory. In addition, comparison of PKD1 +/− and control iPSCs revealed differences in DNA methylation associated with the disease history. In conclusion, we generated and characterized iPSCs derived from cystic andAbstract: Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, leading to kidney failure in most patients. In approximately 85% of cases, the disease is caused by mutations in PKD1 . How dysregulation of PKD1 leads to cyst formation on a molecular level is unknown. Induced pluripotent stem cells (iPSCs) are a powerful tool for in vitro modeling of genetic disorders. Here, we established ADPKD patient-specific iPSCs to study the function of PKD1 in kidney development and cyst formation in vitro. Somatic mutations are proposed to be the initiating event of cyst formation, and therefore, iPSCs were derived from cystic renal epithelial cells rather than fibroblasts. Mutation analysis of the ADPKD iPSCs revealed germline mutations in PKD1 but no additional somatic mutations in PKD1/PKD2 . Although several somatic mutations in other genes implicated in ADPKD were identified in cystic renal epithelial cells, only few of these mutations were present in iPSCs, indicating a heterogeneous mutational landscape, and possibly in vitro cell selection before and during the reprogramming process. Whole-genome DNA methylation analysis indicated that iPSCs derived from renal epithelial cells maintain a kidney-specific DNA methylation memory. In addition, comparison of PKD1 +/− and control iPSCs revealed differences in DNA methylation associated with the disease history. In conclusion, we generated and characterized iPSCs derived from cystic and healthy control renal epithelial cells, which can be used for in vitro modeling of kidney development in general and cystogenesis in particular. : Abstract : Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. Here, we generated induced pluripotent stem cells (iPSCs) of ADPKD patients to study kidney development and cyst formation in vitro. These iPSCs revealed germline and autosomal mutations implicated in ADPKD and displayed an epigenetic memory of kidney epithelial cells, providing powerful models to study ADPKD in vitro. … (more)
- Is Part Of:
- Stem cells translational medicine. Volume 9:Number 4(2020)
- Journal:
- Stem cells translational medicine
- Issue:
- Volume 9:Number 4(2020)
- Issue Display:
- Volume 9, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 4
- Issue Sort Value:
- 2020-0009-0004-0000
- Page Start:
- 478
- Page End:
- 490
- Publication Date:
- 2020-03-12
- Subjects:
- ADPKD -- cyst -- DNA methylation -- epigenetic memory -- iPS cells -- PKD1 -- renal epithelial cells -- second hit -- somatic mutation
Stem cells -- Periodicals
Regenerative medicine -- Periodicals
Periodicals
616.0277405 - Journal URLs:
- https://academic.oup.com/stcltm ↗
http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/issues/ ↗
http://stemcellstm.alphamedpress.org/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/sctm.18-0283 ↗
- Languages:
- English
- ISSNs:
- 2157-6564
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25788.xml